Italian medtech to gain through pharma decision?:
This article was originally published in Clinica
The Italian health ministry is calling on the national pharmaceuticals market to cut the prices of medicines, citing evidence that they are "5% more expensive than the European average". The move is set to be welcomed by the rest of the healthcare industry, following high-profile calls for the standards of care to reflect the high cost of running the service (see Clinica No 969, p 7). In last week's correspondence with the pharmaceuticals industry association Farmindustria, health minister Girolamo Sirchia has stated his intention to adopt the "necessary measures" to correct the situation.